Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria
Clinical trial NCT06072157 · COMPLETED
Trial details
- NCT number
- NCT06072157
- Sponsor
- Allakos Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-28
- Primary completion
- 2025-05-12
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.